Leveraging Biomarkers to De-risk Clinical Development in Complement Mediated Diseases: Progress with Anti-C1q Inhibitor ANX005

Time: 12:30 pm
day: Day Two

Details:

Download the Full Event Guide to find out more 

Speakers: